India's Largest Vaccine Study Shows Covishield Cuts Covid Breakthrough Infection By 93%

Описание: The mega-scale study was conducted among 1.5 million healthcare and frontline workers of the Indian armed forces. Covishield is the made-in-India variant of Oxford-AstraZeneca’s AZD-1222 formulation. It is a predominant vaccine being used in India’s mass inoculation programme against Covid-19.
#covishield #vaccinationindia #covishieldvaccine

Follow CRUX on Instagram (@crux.india): https://bit.ly/3qSFx1K
Follow CRUX on Facebook: https://bit.ly/2Lte7iF
#GetCloserToTheNews with latest headlines on politics, sports and entertainment on news18.com https://bit.ly/2Y4QccL

Also watch:
Crux One Take: https://bit.ly/3oNaLWf
Crux Files: https://bit.ly/3mnbnjW
Crux BTS: https://bit.ly/3oCjbQE